These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24398897)

  • 1. The use of psychiatric drugs and worsening body mass index among inpatients with schizophrenia.
    Wang PS; Wu SL; Ching HY
    Int Clin Psychopharmacol; 2014 Jul; 29(4):235-8. PubMed ID: 24398897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between body mass index, the use of second-generation antipsychotics, and dental caries among hospitalized patients with schizophrenia.
    Chu KY; Yang NP; Chou P; Chi LY; Chiu HJ
    Int J Psychiatry Med; 2011; 41(4):343-53. PubMed ID: 22238839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample.
    Gurpegui M; Martínez-Ortega JM; Gutiérrez-Rojas L; Rivero J; Rojas C; Jurado D
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):169-75. PubMed ID: 22326681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bodyweight in inpatients with schizophrenia].
    Wetterling T; Pest S; Müssigbrodt H; Weber B
    Psychiatr Prax; 2004 Jul; 31(5):250-4. PubMed ID: 15243875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight change by baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database.
    Bushe CJ; Slooff CJ; Haddad PM; Karagianis JL
    J Psychopharmacol; 2013 Apr; 27(4):358-65. PubMed ID: 23343595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight changes and their associations with demographic and clinical characteristics in risperidone maintenance treatment for schizophrenia.
    Xiang YT; Wang CY; Ungvari GS; Kreyenbuhl JA; Chiu HF; Lai KY; Lee EH; Bo QJ; Dixon LB
    Pharmacopsychiatry; 2011 Jun; 44(4):135-41. PubMed ID: 21710403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in body mass index z-scores and weight status in a Dutch pediatric psychiatric population with and without use of second-generation antipsychotics.
    de Hoogd S; Overbeek WA; Heerdink ER; Correll CU; de Graeff ER; Staal WG
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):166-73. PubMed ID: 22506734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate.
    Sliwa JK; Fu DJ; Bossie CA; Turkoz I; Alphs L
    BMC Psychiatry; 2014 Feb; 14():52. PubMed ID: 24559194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
    Bond DJ; Kauer-Sant'Anna M; Lam RW; Yatham LN
    J Affect Disord; 2010 Jul; 124(1-2):108-17. PubMed ID: 19914720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Overweight and obesity in schizophrenia--much more than a life-style issue!].
    Pollmächer T
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):697. PubMed ID: 19053011
    [No Abstract]   [Full Text] [Related]  

  • 12. Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia.
    Kemp DE; Correll CU; Tohen M; Delbello MP; Ganocy SJ; Findling RL; Chang K
    J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):522-30. PubMed ID: 24111982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
    Lee SY; Park MH; Patkar AA; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index, obesity, and psychopathology in patients with schizophrenia.
    Subramaniam M; Lam M; Guo ME; He VY; Lee J; Verma S; Chong SA
    J Clin Psychopharmacol; 2014 Feb; 34(1):40-6. PubMed ID: 24346756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first-episode schizophrenia patients in India: a randomized, double-blind, controlled, prospective study.
    Saddichha S; Manjunatha N; Ameen S; Akhtar S
    J Clin Psychiatry; 2007 Nov; 68(11):1793-8. PubMed ID: 18052574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioelectric impedance is a better indicator of obesity in men with schizophrenia than body mass index.
    Sharpe JK; Byrne NM; Stedman TJ; Hills AP
    Psychiatry Res; 2008 May; 159(1-2):121-6. PubMed ID: 18395268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia.
    Limosin F; Gasquet I; Leguay D; Azorin JM; Rouillon F
    Acta Psychiatr Scand; 2008 Jul; 118(1):19-25. PubMed ID: 18582344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in body mass index for individuals with and without schizophrenia, 1987-1996.
    Homel P; Casey D; Allison DB
    Schizophr Res; 2002 Jun; 55(3):277-84. PubMed ID: 12048151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low rate of obesity among psychiatric inpatients in Indonesia.
    Marthoenis M; Aichberger M; Puteh I; Schouler-Ocak M
    Int J Psychiatry Med; 2014; 48(3):175-83. PubMed ID: 25492712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.